PeptideDB

Helichrysetin

CAS No.: 62014-87-3

Helichrysetin has mild anti-HIV-1 PR activity. Helichrysetin has great potentials for development as an anticancer agent
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Helichrysetin has mild anti-HIV-1 PR activity. Helichrysetin has great potentials for development as an anticancer agent, it has cytotoxic effect on four selected cancer cell lines, A549, MCF-7, Ca Ski, and HT-29.
In vitro Searching for anti-HIV-1 protease (PR) inhibitors of Thai medicinal plants led to the isolation of a new cyclohexenyl chalcone named panduratin C (1) and chalcone derivatives (2-6) from the methanol extract of Boesenbergia pandurata rhizomes. The known compounds were identified to be panduratin A (2), hydroxypanduratin A (3), Helichrysetin (4), 2',4',6'-trihydroxyhydrochalcone (5), and uvangoletin (6). The structures of all compounds were elucidated on the basis of chemical and spectroscopic methods. It was found that 3 possessed the most potent anti-HIV-1 PR activity with an IC50 value of 5.6 microM, followed by 2 (IC50 = 18.7 microM), whereas other compounds exhibited only mild activity.
Synonyms 4,2',4'-三羟基-6'-甲氧基查耳酮, 蜡菊亭
molecular weight 286.28
Molecular formula C16H14O5
CAS 62014-87-3
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMSO: 22.5 mg/mL (78.59 mM)
References 1. Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata.Bioorg Med Chem. 2006 Mar 15;14(6):1710-4.